NEVVI Medicare utilization intelligence
or

← back

Provider profile

HARP, JOANNA M.D.

Dermatology · NPI 1780919746 · SAN FRANCISCO, CA

3
Groups
18
Codes · 2024
2,698
Disclosed services

HARP, JOANNA is a Dermatology in SAN FRANCISCO, CA, a member of 3 medical groups, who billed 18 distinct codes to Medicare Part B in 2024.

Groups: UCSF MEDICAL GROUP BUSINESS SERVICES (SAN FRANCISCO, CA) · UNIVERSITY OF CALIFORNIA SAN FRANCISCO (SAN FRANCISCO, CA) · WEILL MEDICAL COLLEGE OF CORNELL (NEW YORK, NY) — member of 3 groups; the volumes below are this clinician's personal volume and are not attributed to any single group

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

2,698
disclosed services
18
codes billed to Medicare Part B
Prior year · CY2023 2,677 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
17003 Destruction of precancer skin growth, 2-14 growths
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
17000 Destruction of precancer skin growth, 1 growth
17110 Destruction of skin growth, 1-14 growths
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg
11900 Injection into skin growth, 1-7 growths
11102 Biopsy of related skin growth, first growth
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
96900 Application of ultraviolet light to skin
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
99221 Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes
36415 Insertion of needle into vein for collection of blood sample
11104 Punch biopsy, first skin growth
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
17261 Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.